Westford, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Antibiotics Market will reach a value of USD 72.65 Billion by 2031, with a CAGR of 4.10% during the forecast period (2024-2031). Antibiotics are the major parts of the pharmaceutical industry, impacted by the rising need to treat several bacterial infections. It comprises products, such as cephalosporins, penicillins, and macrolides. In recent years, there has been a growing interest in developing alternate and novel antibiotics to fight resistant strains. Moreover, the growing elderly population and increasing cases of infections are the key factors driving the growth of the antibiotics market.
Antibiotics Market Overview:
| Report Coverage | Details |
| Market Revenue in 2023 | USD 52.67 Billion |
| Estimated Value by 2031 | USD 72.65 Billion |
| Growth Rate | Poised to grow at a CAGR of 4.10% |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Drug Class, Action Mechanism, and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa |
| Report Highlights | Growing number of patent filings by major market players |
| Key Market Opportunities | Introduction of New Combination Therapies |
| Key Market Drivers | Rising Incidences of Infectious Diseases |
Explore Comprehensive Insights into The Global Antibiotics Market with A Detailed Sample Report: https://www.skyquestt.com/sample-request/antibiotics-market
Antibiotics Market Segmental Analysis
Global Antibiotics Market is segmented by Drug Class, Type, Action Mechanism, and region.
Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, and Others.
Based on Type, the market is segmented into Branded Antibiotics, Generic Antibiotics.
Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Penicillin Segment to Hold Major Market Share Owing to its Wide Applications in Treating Different Infectious Diseases
By drug class, the penicillin segment held a significant market share in the past years and is expected to lead over the estimated period owing to their broader applications in treating diverse bacterial infections. These drugs are highly preferred in treating illnesses like skin contamination, pharyngitis, ear contamination, gonorrhea, and bronchitis. They are regarded as foundational antibiotics and are increasingly prescribed, thus the segment’s growth. Conversely, the cephalosporin segment is projected to grow considerably over the forecast period owing to their high effectiveness against bacterial infections, comprising those resilient to other antibiotics.
Cell Wall Synthesis Segment Leads Market Due to Significant Investments by Governments
By action mechanism, the cell wall synthesis segment registered for a remarkable market share in the past years and will continue to dominate in the future as well owing to widespread applications as per remedy designs and major investments by governments. These inhibitors are prominently used since they present major activities against negative microbes and gram-positive microbes. Hence, the growing number of research activities is fueling the growth of the segment. On the other hand, the RNA synthesis segment is expected to hold a notable market share over the forecast period owing to its efficacy. Antibiotics aiming RNA synthesis, such as rifamycin are significantly effective for a broader range of bacterial infections, which is important for transcription. Also, the resistant management nature is further driving the growth of the segment.
Ask for Customization: https://www.skyquestt.com/speak-with-analyst/antibiotics-market
Asia-Pacific to Dominate the Market Owing to Expansive Use of Antibiotics
Geographically, Asia-Pacific dominated the market in 2023 and is expected to lead over the estimated period as well owing to the expansion of infectious diseases, growing government investments for the development of new treatments, and increased use of antibiotics. Moreover, China and India are the leading business sectors for the said market, impacting the regional growth. Other key factors supporting the market growth in the region include unregulated deals and excessive use of antibiotics.
North America is projected to lead as the second-largest region owing to the progressed healthcare infrastructure, rising cases of infectious diseases, and supportive government initiatives like antibiotic stewardship. This is notable propelling several research activities to control the growing number of infections. In addition, the business sectors are notably focused on the use of improved technologies, thus impacting the market growth in the region.
Antibiotics Market Insight
Drivers:
- Government Funding and Initiatives
- Pharmaceutical Innovations
- Growing Number of Chronic Illnesses
Restraints:
- Antibiotic Resistance
- Significant Research and Development Costs
- Regulatory Issues
Prominent Players in Antibiotics Market
- Pfizer Inc.
- GlaxoSmithKline plc. (GSK)
- Sanofi S.A.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- F. Hoffmann-La Roche AG
- AstraZeneca PLC
- Bayer AG
- Abbott Laboratories
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Cipla Ltd
- AbbVie, Inc.
- Lupin Pharmaceuticals, Inc.
- Viatris, Inc.
- Melinta Therapeutics LLC
- Cipla, Inc.
- Shionogi & Co., Ltd.
- KYORIN Pharmaceutical Co., Ltd.
- Nabriva Therapeutics PLC
Take Action Now: Secure Your Antibiotics Market Today - https://www.skyquestt.com/sample-request/antibiotics-market
Key Questions Answered in Global Antibiotics Market Report
- What is the estimated value of global antibiotics market by 2031, as per to SkyQuest Technology?
- What are the leading factors driving the Antibiotics Market?
- What are the commonly adopted strategies adopted by the players profiled in the antibiotics market?
This report provides the following insights:
Analysis of key drivers (growing awareness and education, growing elderly population, improvements in healthcare infrastructure), restraints (economic constraints, market access challenges, limited market returns), opportunities (improvements in biotechnology, emphasis on combination therapies, novel drug delivery systems), and challenges (strict regulatory needs, misuse and overuse, complex supply chains) influencing the growth of antibiotics market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the antibiotics market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the antibiotics market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Browse Full Report Here - https://www.skyquestt.com/report/antibiotics-market
Related Reports –
Softgel Capsule Market is growing at a CAGR of 7.9% in the forecast period (2024-2031)
Acne Treatment Market is growing at a CAGR of 4.63% in the forecast period (2024-2031)
Animal Antibiotics and Antimicrobials Market is growing at a CAGR of 3.5% in the forecast period (2024-2031)
Radiodermatitis Market is growing at a CAGR of 4.2% in the forecast period (2024-2031)
Macrolide Antibiotics Market is growing at a CAGR of 2.3% in the forecast period (2024-2031)
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
